Virogenetics Corporation
Records under this name other than patents Virogenetics Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Virogenetics Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,017,537 | Formyl methionyl peptide vaccine adjuvant Term ended Term ended Dec 18, 2018 · USPTO record | Term ended | Term ended Dec 18, 2018 | USPTO record |
| US 6,265,189 | Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen Term ended Term ended Jul 24, 2018 · USPTO record | Term ended | Term ended Jul 24, 2018 | USPTO record |
| US 6,130,066 | Vectors having enhanced expression and methods of making and uses thereof Term ended Term ended May 15, 2018 · USPTO record | Term ended | Term ended May 15, 2018 | USPTO record |
| US 6,017,542 | Nucleotide and amino acid sequences of canine herpesvirus GD and uses therefor Term ended Term ended Jan 25, 2017 · USPTO record | Term ended | Term ended Jan 25, 2017 | USPTO record |
| US 7,255,862 | ALVAC/FIV constructs Term ended Term ended Nov 14, 2016 · USPTO record | Term ended | Term ended Nov 14, 2016 | USPTO record |
| US 6,090,393 | Recombinant canine adenoviruses, method for making and uses thereof Formerly held Term ended Term ended Jul 3, 2016 · USPTO record | Term ended | Term ended Jul 3, 2016 | USPTO record |
| US 6,632,438 | Recombinant poxvirus cytomegalovirus, compositions, and uses Lapsed on the fee record Ended Oct 14, 2011 · USPTO record | Lapsed on the fee record | Ended Oct 14, 2011 | USPTO record |
| US 6,596,279 | Immunodeficiency recombinant poxvirus Term ended Term ended Mar 7, 2011 · USPTO record | Term ended | Term ended Mar 7, 2011 | USPTO record |
| US 6,267,965 | Recombinant poxvirus--cytomegalovirus compositions and uses Lapsed on the fee record Ended Jul 31, 2009 · USPTO record | Lapsed on the fee record | Ended Jul 31, 2009 | USPTO record |
| US 6,537,594 | Vaccina virus comprising cytokine and/or tumor associated antigen genes Lapsed on the fee record Ended Mar 25, 2007 · USPTO record | Lapsed on the fee record | Ended Mar 25, 2007 | USPTO record |